Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab-treated patients.
about
Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab-treated patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Serum osteopontin: a biomarker ...... tocilizumab-treated patients.
@en
Serum osteopontin: a biomarker ...... tocilizumab-treated patients.
@nl
type
label
Serum osteopontin: a biomarker ...... tocilizumab-treated patients.
@en
Serum osteopontin: a biomarker ...... tocilizumab-treated patients.
@nl
prefLabel
Serum osteopontin: a biomarker ...... tocilizumab-treated patients.
@en
Serum osteopontin: a biomarker ...... tocilizumab-treated patients.
@nl
P2093
P2860
P1433
P1476
Serum osteopontin: a biomarker ...... tocilizumab-treated patients.
@en
P2093
Ana García-Martínez
Ariel Ponce
Chie Miyabe
Georgina Espígol-Frigolé
Giuseppe Murgia
Itziar Tavera-Bahillo
Javier Marco-Hernández
José Hernández-Rodríguez
Marc Corbera-Bellalta
Marco A Alba
P2860
P304
P356
10.1136/RMDOPEN-2017-000570
P577
2017-12-22T00:00:00Z